A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma

Glioblastoma (GBM) is a fatal disease, with poor prognosis exacerbated by difficulty in assessing tumor extent with imaging. Spectroscopic MRI (sMRI) is a non-contrast imaging technique measuring endogenous metabolite levels of the brain that can serve as biomarkers for tumor extension. We completed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, Karthik K., Huang, Vicki, Rosenthal, Jeffrey, Mellon, Eric A., Goryawala, Mohammed, Barker, Peter B., Gurbani, Saumya S., Trivedi, Anuradha G., Giuffrida, Alexander S., Schreibmann, Eduard, Han, Hui, de le Fuente, Macarena, Dunbar, Erin M., Holdhoff, Matthias, Kleinberg, Lawrence R., Shu, Hui-Kuo G., Shim, Hyunsuk, Weinberg, Brent D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964256/
https://www.ncbi.nlm.nih.gov/pubmed/36828381
http://dx.doi.org/10.3390/tomography9010029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964256/
https://www.ncbi.nlm.nih.gov/pubmed/36828381
http://dx.doi.org/10.3390/tomography9010029

Ejemplares similares